Limba
Romanian
Romanian
English|
PHI-101 is an orally active, potent third-generation inhibitor of FLT3that overcomes resistance to multiple drug-resistant mutations. It has potential for research in relapsed or refractory acute myeloid leukemia (AML).
| Price | 2.884,00 RON (preturile sunt fara TVA) |
|---|---|
| Description |
PHI-101 is an orally active, potent third-generation inhibitor of FLT3that overcomes resistance to multiple drug-resistant mutations. It has potential for research in relapsed or refractory acute myeloid leukemia (AML). |
